85363-04-8

Basic information

• Product Name: N-(tert-Butoxycarbonyl)-2-aminoacetonitrile
• Synonyms: N-(TERT-BUTOXYCARBONYL)-2-AMINOACETONITRILE;BOC-2-AMINOACETONITRILE;BOC-GLY-NITRILE;AKOS 91568;Carbamic acid, (cyanomethyl)-, 1,1-dimethylethyl ester (9CI);N-BOC-2-Aminoacetonitrile;2-(Boc-aMino)acetonitrile;N-(tert-Butoxycarbonyl)-2-aminoacetonitrile 97%
• CAS NO: 85363-04-8
• Molecular Formula: C₇H₁₂N₂O₂
• Molecular Weight: 156.18
• Product Categories: N-BOC;C6 to C7;Cyanides/Nitriles;Nitrogen Compounds
• Mol File: 85363-04-8.mol
• Article Data: 22

Chemical Properties

• Melting Point: 53-57 °C(lit.)
• Boiling Point: 186 °C(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 1.1832 (rough estimate)
• Refractive Index: 1.4880 (estimate)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 9.96±0.46(Predicted)
• CAS DataBase Reference: N-(tert-Butoxycarbonyl)-2-aminoacetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: N-(tert-Butoxycarbonyl)-2-aminoacetonitrile(85363-04-8)
• EPA Substance Registry System: N-(tert-Butoxycarbonyl)-2-aminoacetonitrile(85363-04-8)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22
• Safety Statements: 36
• WGK Germany: 3
• Hazardous Substances Data: 85363-04-8(Hazardous Substances Data)

Usage

Uses

N-(tert-Butoxycarbonyl)-2-aminoacetonitrile may be used for the preparation of N-(tert-butoxycarbonyl)-2-aminoacetamidoxime, by reaction with hydroxylamine hydrochloride.

General Description

N-(tert-Butoxycarbonyl)-2-aminoacetonitrile is an organic building block.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 151-63-3 cyanomethylamine sulfate 
• 4530-20-5 BOC-glycine 
• 172876-96-9 3-oxo-1λ³-benzo[d][1,2]iodaoxole-1(3H)-carbonitrile 
• 22821-76-7 4-(methylsulfonyl)benzonitrile 
• 51779-32-9 iminodicarboxylic acid di-tert-butyl ester 
• 35150-09-5 N-(tert-butoxycarbonyl)glycine 
• 6011-14-9 2-aminoacetonitrile hydrochloride 

Downstream Products

• 218164-28-4 Boc-Aca-OH 
• 479079-15-7 tert-butyl [2-amino-2-(hydroxyimino)ethyl]carbamate 
• 479079-15-7 tert-butyl [(2Z)-2-amino-2-(hydroxyimino)ethyl]carbamate 
• 540-61-4 2-aminoacetonitrile 
• 486402-88-4 (1-benzyl-1H-tetrazol-5-ylmethyl)-carbamic acid tert-butyl ester 
• 85363-08-2 4-{(S)-2-[(6-{[Benzyloxycarbonyl-(2-tert-butoxycarbonylamino-ethyl)-amino]-methyl}-pyridine-2-carbonyl)-amino]-2-methoxycarbonyl-ethyl}-imidazole-1-carboxylic acid benzyl ester 
• 71904-80-8 2-((tert-butoxycarbonylamino)methyl)thiazole-4-carboxylic acid 
• 930272-56-3 2-(tert-butoxycarbonyl-aminomethyl)-5-methylpyrimidine 
• 115894-70-7 tert-butyl ((2H-tetrazol-5-yl)methyl)carbamate 
• 479079-15-7 tert-butyl 2-(hydroxyamino)-2-iminoethylcarbamate 
• 1373278-78-4 methyl 5-(7-(5-((tert-butoxycarbonylamino)methyl)isoxazol-3-yl)-3-(4-fluorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)pentanoate 
• 1360686-98-1 tert-butyl ((3-tert-butyl-1-(3-chlorophenyl)-1H-1,2,4-triazol-5-yl)methyl)carbamate 

Relevant articles and documents

A convenient large scale synthesis of N-BOC-ethylenediamine

-

Design, synthesis and cytotoxic evaluation of a library of oxadiazole-containing hybrids

The development of hybrid compounds led to the discovery of new pharmacologically active agents for some of the most critical diseases, including cancer. Herein, we describe a new series of oxadiazole-containing structures designed by a molecular hybridiz

Decarboxylative Cyanation of Aliphatic Carboxylic Acids via Visible-Light Flavin Photocatalysis

An operationally simple method is disclosed for the decarboxylative cyanation of aliphatic carboxylic acids at room temperature. Riboflavin tetraacetate, which is an inexpensive organic photocatalyst, promotes the oxidation of carboxylic acids upon visible-light activation. After decarboxylation, the generated radicals are trapped by TsCN, yielding the desired nitriles without any further additive, in a redox-neutral process. Importantly, this protocol can be adapted to flow conditions.

7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS

Compounds of Formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof, their preparation, and use in treating a bacterial infection are disclosed.